New pain drug could replace morphine for teens after back surgery

NCT ID NCT07229495

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests if a new pain medicine called tegileridine works as well as morphine for teenagers recovering from scoliosis surgery. About 171 teens will receive either tegileridine or morphine through a pump they control. Researchers will compare pain levels and side effects over the first 24 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tegileridine
What this could lead to
If it works, this could offer a new pain relief option for teenagers after spinal surgery, potentially with fewer side effects than morphine.
What could go wrong
This is a Phase 4 trial, but it's still early and small (171 participants). The new drug may not be as effective or safe as hoped, and side effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANALGESIA, PATIENT-CONTROLLED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Chao-yang Hospital, Capital Medical University

    Beijing, 100020, China

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, 450003, China

  • Peking Union Medical College Hospital

    Beijing, 100730, China

  • Shanghai Children's Medical Centre, School of Medicine, Shanghai Jiao Tong University

    Shanghai, 200127, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, 330006, China

  • Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, 200092, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.